What age is the peak onset for multiple myeloma?
William Smith
Updated on April 02, 2026
The peak age of disease onset is 65 years of age, but recent statistics indicate the disease is becoming more prevalent and that people are getting the disease at younger ages. In multiple myeloma, the body produces too many plasma or myeloma cells.
Can you live 25 years with myeloma?
The SEER(Surveillance, Epidemiology, and End Results) data for multiple myeloma has been published in 2013 by the National Cancer Institute, and the average life expectancy remains at 4 years for the third year in a row. However, some people beat the odds and live 10 to 20 years or more.
Is multiple myeloma hard to treat?
Multiple myeloma is very hard to cure, although allogeneic stem cell transplantation has cured patients with the disease. Unfortunately, however, allogeneic transplantation can only be used in a minority of patients with myeloma due to donor availability and age limitations.
Does multiple myeloma ever go into remission?
Chemotherapy and other treatments kill multiple myeloma cells and put you into remission, which means your tests no longer show any signs of cancer. Relapsed or recurrent multiple myeloma is when the cancer comes back after you were in remission.
Can you live a normal life with multiple myeloma?
Multiple myeloma is a type of cancer that affects the bone marrow. Multiple myeloma is a cancer of bone marrow. Bone marrow is the spongy tissue inside the long bones….How long can a person live with multiple myeloma?
| Revised international staging system | Median survival |
|---|---|
| Stage I | 62 months (5 years, 2 months) |
What is the best treatment for multiple myeloma?
Treatment for multiple myeloma includes drugs that modulate the immune system, chemotherapy drugs, radiation therapy, stem cell transplants and, in some patients, surgery.
What are warning signs of multiple myeloma?
Exhaustion: unusual level of fatigue that fails to go away,even accompanied with a healthy diet and adequate rest.
How effective is Revlimid for multiple myeloma?
Multiple myeloma. Revlimid was more effective than placebo (a dummy treatment) in two main studies in 1,074 patients with newly diagnosed multiple myeloma and who had had stem cell transplantation. The main measure of effectiveness was how long patients lived without their cancer getting worse.
How does Revlimid treat multiple myeloma?
Revlimid, also known as lenalidomide, is an oral cancer drug that is used for the treatment of multiple myeloma. It is part of a class of drugs called immunomodulatory drugs (IMiDs), which work against cancer cells partly by supporting the function of the immune system. Revlimid is manufactured by Celgene.
